These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2504817)

  • 1. The renal antihypertensive endocrine function: its relation to cytochrome P-450.
    Muirhead EE; Byers LW; Capdevila J; Brooks B; Pitcock JA; Brown PS
    J Hypertens; 1989 May; 7(5):361-9. PubMed ID: 2504817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal vasodepressor mechanisms: the medullipin system.
    Muirhead EE
    J Hypertens Suppl; 1993 Dec; 11(5):S53-8. PubMed ID: 8158434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive polar and neutral renopapillary lipids. Which is a hormone?
    Muirhead EE; Byers LW; Folkow B; Göthberg G; Thorén P; Brooks B
    Hypertension; 1983; 5(6 Pt 3):V61-5. PubMed ID: 6654466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullipin system. Generation of medullipin II by isolated kidney-liver perfusion.
    Muirhead EE; Brooks B; Byers LW; Brown P; Pitcock JA
    Hypertension; 1991 Nov; 18(5 Suppl):III158-63. PubMed ID: 1937680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver converts the antihypertensive hormone of the kidney. The renohepatic axis.
    Muirhead EE; Byers LW; Brooks B; Dowell R
    Hypertension; 1986 Jun; 8(6 Pt 2):II117-22. PubMed ID: 3721554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of medullipin I by isolated kidneys perfused under elevated pressure.
    Muirhead EE; Brooks B; Byers LW; Brown P; Pitcock JA
    Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):409-17. PubMed ID: 1914243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension.
    Zou AP; Muirhead EE; Cowley AW; Mattson DL; Falck JR; Jiang J; Roman RJ
    J Hypertens; 1995 May; 13(5):557-66. PubMed ID: 7561014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of medullipin I by the kidney involves the cytochrome P-450 enzyme system.
    Muirhead EE; Brooks B; Byers LW
    J Hypertens; 1994 Feb; 12(2):155-8. PubMed ID: 8021466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihypertensive function of the kidney. Its elucidation by captopril plus unclipping.
    Muirhead EE; Pitcock JA; Nasjletti A; Brown P; Brooks B
    Hypertension; 1985; 7(3 Pt 2):I127-35. PubMed ID: 2581897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of neutral antihypertensive lipid from renal venous effluent in rats.
    Muirhead EE; Byers LW; Pitcock JA; Desiderio DM; Brooks B; Brown P; Brosius WL
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():331s-333s. PubMed ID: 7318334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of medullipin I by the kidney requires oxygen.
    Muirhead EE; Brooks B; Byers LW
    J Hypertens; 1992 Sep; 10(9):963-7. PubMed ID: 1328377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver.
    Muirhead EE
    Agents Actions Suppl; 1987; 22():73-84. PubMed ID: 3324720
    [No Abstract]   [Full Text] [Related]  

  • 13. The medullipin system of blood pressure control.
    Muirhead EE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):556S-568S. PubMed ID: 1741992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive action of medullipin I given by mouth.
    Muirhead EE; Brooks B; Byers LW; Toba K; Share L
    Hypertension; 1991 Jun; 17(6 Pt 2):1092-6. PubMed ID: 2045154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
    Muirhead EE; Byers LW; Desiderio DM; Pitcock JA; Brooks B; Brown PS; Brosius WL
    J Lab Clin Med; 1982 Jan; 99(1):64-75. PubMed ID: 6798154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of medullipin I by the liver.
    Muirhead EE; Brooks B; Byers LW; Pitcock JA; Brown PS
    Trans Assoc Am Physicians; 1988; 101():226-34. PubMed ID: 3269681
    [No Abstract]   [Full Text] [Related]  

  • 17. The vasodepressor function of the kidney: further characterization of medullipin and a second hormone designated angiolysin.
    Glodny B; Pauli GF
    Hypertens Res; 2006 Jul; 29(7):533-44. PubMed ID: 17044666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.
    Muirhead EE; Folkow B; Byers LW; Desiderio DM; Thorén P; Göthberg G; Dow AW; Brooks B
    Hypertension; 1983; 5(2 Pt 2):I112-8. PubMed ID: 6826221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat.
    Oyekan AO; McGiff JC; Quilley J
    Circ Res; 1991 Apr; 68(4):958-65. PubMed ID: 1901256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.
    Fulton D; McGiff JC; Quilley J
    Br J Pharmacol; 1992 Nov; 107(3):722-5. PubMed ID: 1472970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.